XML 41 R30.htm IDEA: XBRL DOCUMENT v3.24.3
Net Loss Per Share (Tables)
9 Months Ended
Sep. 30, 2024
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Net Loss Per Share
Basic and diluted net loss per share for the three and nine months ended September 30, 2024 and 2023 are calculated as follows:
Three Months Ended September 30,
20242023
Numerator:
    Net loss$(25,165,478)$(33,929,864)
Denominator:
     Shares used to compute net loss per share, basic and diluted
          Weighted-average common shares outstanding26,005,020 22,385,229 
          Weighted-average pre-funded warrants2,135,477 — 
     Weighted-average common shares outstanding used to compute basic and diluted net loss per share28,140,497 22,385,229 
Net loss per share
     Basic and diluted$(0.89)$(1.52)
Nine Months Ended September 30,
20242023
Numerator:
    Net loss$(87,872,447)$(110,113,714)
Denominator:
     Shares used to compute net loss per share, basic and diluted
          Weighted-average common shares outstanding24,923,227 21,986,840 
          Weighted-average pre-funded warrants1,293,756 — 
     Weighted-average common shares outstanding used to compute basic and diluted net loss per share26,216,983 21,986,840 
Net loss per share
     Basic and diluted$(3.35)$(5.01)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following table summarizes potential shares of common stock that were excluded from the diluted net loss per share calculation because of their anti-dilutive effect:
Three and Nine Months Ended September 30
20242023
Options to purchase common stock1,319,769 1,209,989 
Service-based restricted stock units326,108 277,440 
Performance-and market-based restricted stock units
83,800 — 
Convertible preferred stock275 275 
Convertible notes— 254,165 
Total1,729,952 1,741,869